The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-018-37259-2.pdf
Reference59 articles.
1. Pantel, K. & Brakenhoff, R. H. Dissecting the metastatic cascade. Nat Rev Cancer 4, 448–456, https://doi.org/10.1038/nrc1370 (2004).
2. Andreasen, P. A., Kjoller, L., Christensen, L. & Duffy, M. J. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72, 1–22 (1997).
3. Harbeck, N. et al. Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients. Eur J Cancer 49, 1825–1835, https://doi.org/10.1016/j.ejca.2013.01.007 (2013).
4. Look, M. P. et al. Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. J Natl Cancer Inst 94, 116–128 (2002).
5. Krop, I. et al. Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 35, 2838–2847, https://doi.org/10.1200/JCO.2017.74.0472 (2017).
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Haemostatic Proteins as Markers of Disease Progression and Prognosis in Breast Cancer;2024-07-12
2. ALDH1A3 promotes invasion and metastasis in triple‐negative breast cancer by regulating the plasminogen activation pathway;Molecular Oncology;2023-10-09
3. The Enigma of Mammaglobin: Redefining the Biomarker Paradigm in Breast Carcinoma;International Journal of Molecular Sciences;2023-08-29
4. An Impedimetric Biosensing Strategy Based on BicyclicPeptides as Bioreceptors for Monitoring h-uPA Cancer Biomarkers;Chemosensors;2023-04-09
5. Engineered Macrophages‐Based uPA‐Scavenger Load Gemcitabine to Prompt Robust Treating Cancer Metastasis;Advanced Healthcare Materials;2023-03-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3